CDC Labels 2025–26 Flu Season “Moderately Severe” After Winter Surge

The U.S. Centers for Disease Control and Prevention, based in Atlanta, has classified the 2025–26 influenza season as “moderately severe,” citing elevated influenza activity through late December and estimating at least 11 million illnesses, roughly 120,000 hospitalizations and about 5,000 deaths across the United States. The agency’s assessment reflects what federal officials describe as a stronger-than-expected winter wave that has already translated into significant clinical and operational impacts.

The CDC’s numeric estimates are presented as agency figures; the public statement did not include detailed methodological notes, age or regional breakdowns, or the precise date of the release. Those absences limit the ability to pinpoint where transmission has been most intense and which populations have borne the heaviest burden. The illness estimate is described as “at least” 11 million, implying a lower bound, while hospitalization and death figures are presented as rounded counts.

Public health experts and hospital leaders say the classification will have practical consequences. Higher influenza activity increases demand for primary care, urgent care and emergency departments, and it compounds staffing shortages in hospitals already stretched by other seasonal respiratory viruses. Even without granular CDC data, the projected scale of hospitalizations suggests notable strain on inpatient capacity and intensive care units in some areas.

Beyond clinical strain, the season has equity implications. Influenza typically hits marginalized groups harder when access to vaccination, timely antiviral treatment and paid sick leave is uneven. Communities of color, low-income workers and people in congregate settings often face greater exposure risks and barriers to care. Public health officials say targeted outreach and access programs are essential to reduce severe outcomes, though the CDC’s current statement does not specify specific guidance or expanded measures accompanying the classification.

The federal assessment also raises policy questions about preparedness and prevention. Vaccine uptake and match to circulating strains influence seasonal severity, but the CDC’s announcement does not include information about vaccine effectiveness or dominant viral types for this season. State and local health departments will need up-to-date surveillance data to tailor responses, including boosting vaccination campaigns, ensuring antiviral supply in clinical settings and supporting hospitals with staffing and surge capacity.

Advocates for health equity urge that response planning include concrete steps to reach underserved populations: mobile vaccination clinics, community partnerships for outreach, language-accessible information and policies that reduce financial barriers to care. Advocates also point to broader systemic gaps, including underfunded public health infrastructure and inconsistent paid sick leave policies, that worsen outcomes during seasonal surges.

Going forward, the CDC’s classification should prompt more detailed reporting from the agency on age, regional and demographic impacts, and on the surveillance indicators behind the “moderately severe” label. In the meantime, clinicians and public health officials face the immediate tasks of managing clinical demand, protecting high-risk patients and directing prevention efforts where they are most needed to limit further hospitalizations and deaths.